I will share all of Boston's upcoming events through the CMTA website as well as our page CMT is the most commonly inherited peripheral neuropathy and affects 2.6 million worldwide. Visit our site at www.cmtausa.org! Mission
Our mission is to generate the resources to find a cure, to create awareness, and to improve the quality of life for those affected by Charcot-Marie-Tooth. The time is now: Our vision is a world without CMT! Description
Charcot-Marie-Tooth, or CMT, is the most commonly inherited peripheral neuropathy and is found worldwide among all races and ethnic groups. Discovered in 1886 by three physicians, Jean-Martin Charcot, Pierre Marie, and Howard Henry Tooth, CMT affects an estimated 2.6 million people. For more information, click here: http://cmtausa.org/index.php?option=com_content&view=article&id=70&Itemid=41
General Information
The CMTA is a 501(C)(3)nonprofit organization founded in 1983 whose goals are patient support, public education, promotion of research and ultimately the treatment and cure of CMT. A voluntary Board of Directors governs the CMTA. The Medical Advisory Board of the CMTA consists of over 50 clinical and research medical professionals. This international group of men and women are noted CMT experts in neurology, genetics, orthopedic surgery, physiatry, physical therapy and podiatry. The CMTA currently has more than 20,000 patients and families, supportive friends, and medical professionals in its database.
